Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.

Previous linkage analyses of 19 cutaneous malignant melanoma/dysplastic nevi (CMM/DN) kindreds showed significant evidence of linkage and heterogeneity to both chromosomes 1p and 9p. Five kindreds also showed evidence of linkage (Z>0.7) to both regions. To further examine these findings, we conducted two-trait-locus, two-marker-locus linkage analysis. We examined one homogeneity and one heterogeneity single-locus model (SL-Hom and SL-Het), and two-locus (2L) models: an epistatic model (Ep), in which CMM was treated as a genuine 2L disease, and a heterogeneity model (Het), in which CMM could result from disease alleles at either locus. Both loci were modeled as autosomal dominant. The LOD scores for CMM alone were highest using the SL-Het model (Z = 8.48, theta = .0). There was much stronger evidence of linkage to chromosome 9p than to 1p for CMM alone; the LOD scores were approximately two times greater on 9p than on 1p. The change in LOD scores from an evaluation of CMM alone to CMM/DN suggested that a chromosome 1p locus (or loci) contributed to both CMM and CMM/DN, whereas a 9p locus contributed more to CMM alone. For both 2L models, the LOD scores from 1p were greater for CMM/DN than for CMM alone (Ep: Z=4.63 vs. 3.83; Het: 4.94 vs. 3.80, respectively). In contrast, for 9p, the LOD scores were substantially lower with CMM/DN than with CMM alone (Ep: 4.64 vs. 7.06; Het: 5.38 vs. 7.99, respectively). After conditioning on linkage to the other locus, only the 9p locus consistently showed significant evidence for linkage to CMM alone. Thus, the application of 2L models may be useful to help unravel the complexities of familial melanoma.

[1]  A M Goldstein,et al.  Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. , 1995, The New England journal of medicine.

[2]  N. Hayward,et al.  Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds. , 1995, Human molecular genetics.

[3]  M. Serrano,et al.  A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma , 1995, Science.

[4]  K. Lange,et al.  Computer programs for multilocus haplotyping of general pedigrees. , 1995, American journal of human genetics.

[5]  H. Varmus,et al.  Mutations associated with familial melanoma impair p16INK4 function , 1995, Nature Genetics.

[6]  R. DePinho,et al.  Inhibition of ras-induced proliferation and cellular transformation by p16INK4 , 1995, Science.

[7]  M. Skolnick,et al.  Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). , 1994, Cancer research.

[8]  J. A. Bishop,et al.  Genetic heterogeneity in familial malignant melanoma. , 1994, Human molecular genetics.

[9]  S A Seuchter,et al.  Two-locus disease models with two marker loci: the power of affected-sib-pair tests. , 1994, American journal of human genetics.

[10]  W. Clark,et al.  Germline p16 mutations in familial melanoma , 1994, Nature Genetics.

[11]  D. Carson,et al.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.

[12]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[13]  W. Clark,et al.  Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity. , 1994, American journal of human genetics.

[14]  J D Terwilliger,et al.  Two-locus linkage analysis in multiple sclerosis (MS). , 1994, Genomics.

[15]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[16]  N. Schork,et al.  Two-trait-locus linkage analysis: a powerful strategy for mapping complex genetic traits. , 1993, American journal of human genetics.

[17]  J. Weber,et al.  Confirmation of chromosome 9p linkage in familial melanoma. , 1993, American journal of human genetics.

[18]  J. Weber,et al.  Linkage analysis in Dutch familial atypical multiple mole-melanoma (FAMMM) syndrome families. Effect of naevus count. , 1993, Melanoma research.

[19]  W. Clark,et al.  Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity. , 1993, American journal of human genetics.

[20]  M. Skolnick,et al.  Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. , 1992, Science.

[21]  N. Hayward,et al.  Exclusion of the familial melanoma locus (MLM) from the PND/D1S47 and MYCL1 regions of chromosome arm 1p in 7 Australian pedigrees. , 1992, Genomics.

[22]  R. Kefford,et al.  Hereditary melanoma in Australia. Variable association with dysplastic nevi and absence of genetic linkage to chromosome 1p. , 1991, Cancer genetics and cytogenetics.

[23]  M. Skolnick,et al.  Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome Ip36. , 1990, American journal of human genetics.

[24]  M. Nelen,et al.  Exclusion of the dysplastic nevus syndrome (DNS) locus from the short arm of chromosome 1 by linkage studies in Dutch families. , 1989, Genomics.

[25]  P. Green,et al.  Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. , 1989, The New England journal of medicine.

[26]  J. Ott,et al.  Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. , 1985, American journal of human genetics.

[27]  W. Clark,et al.  Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families. , 1983, The Journal of pediatrics.

[28]  J. Ott,et al.  A simple scheme for the analysis of HLA linkages in pedigrees , 1978, Annals of human genetics.

[29]  B. Childs,et al.  Genetic heterogeneity. , 1968, The New England journal of medicine.